Abstract:Osteoporosis, a chronic disease that affects over 200 million people worldwide, presents a substantial medical and socioeconomic burden on the modern society. However, long-term intake of diets supplemented with different polyunsaturated fatty acids (PUFAs) can affect bone metabolism; thus, this study investigated the comparative effects of Antarctic krill oil (AKO, containing n-3 PUFAs) and arachidonic acid-rich oil (AAO, containing n-6 PUFAs) on bone resorption in a mice model of postmenopausal osteoporosis. Mice were orally administered with AKO (200 mg kg(-1)) or AAO (220 mg kg(-1)) once daily for 30 days, ovariectomized, followed by the continued administration of the respective samples for 90 days. Biomechanical and histomorphometric analyses revealed that AKO increased the bone mineral density (BMD) to enhance the biomechanical properties by increasing the mineral apposition rate and repairing the microstructure of the trabecular bone, whereas AAO had the opposite effect. The fatty acid analysis of the vertebra showed that AKO increased the n-3 PUFA (especially for DHA) content, thereby decreasing the ratio of n-6/n-3 PUFAs, which was negatively correlated with the BMD. However, AAO had the opposite effect due to high amounts of arachidonic acid. To explore the underlying mechanism responsible for these observations, we compared the classical bone resorption OPG/RANKL/NF-kappa B pathway mediated by PGE(2)/EP4. The ratio of n-6/n-3 PUFAs in the bone affected the production of PGE(2), a factor regulating the OPG/RANKL pathway, thereby regulating osteoclastogenesis by stimulating the NF-kappa B pathway. The results of ELISA, qRT-PCR, and western blot demonstrated that AKO reduced the secretion of PGE(2)and the expression of EP4, upregulating the ratio of OPG/RANKL in the bone, thereby decreasing TRAF6 expression to inhibit the activation of the NF-kappa B signaling pathway, and finally inhibiting the expression of nuclear transcription factors (c-fos and NFATc1) to prevent excessive osteoclastogenesis (TRACP, MMP-9, and Cath-K). Arachidonic acid is a precursor of PGE(2)synthesis. AAO showed the opposite trend through the same pathway. Thus, AKO could significantly improve osteoporosisviathe OPG/RANKL/NF-kappa B pathway mediated by PGE(2)/EP(4)to inhibit osteoclastogenesis, whereas AAO aggravated osteoporosisviathe same pathway. This is the first study to systematically compare the effects and mechanism of AKO and AAO in regulating bone resorption in osteoporotic mice to support recommendations on fatty acid types in dietary oils for an osteoporotic population.

Eicosapentaenoic Acid Supplementation Modulates the Osteoblast/Osteoclast Balance in Inflammatory Environments and Protects Against Estrogen Deficiency-induced Bone Loss in Mice

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss Via Suppressing Osteoclastogenesis in Mice

12-Deoxyphorbol 13-Acetate Inhibits RANKL-induced Osteoclastogenesis Via the Attenuation of MAPK Signaling and NFATc1 Activation

Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear fact

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1

The opposite effects of<i>Antarctic krill</i>oil and arachidonic acid-rich oil on bone resorption in ovariectomized mice

Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro.

The combination of Butyricicoccus pullicaecorum and 3-hydroxyanthranilic acid prevents postmenopausal osteoporosis by modulating gut microbiota and Th17/Treg

Docosahexaenoic Acid-Enriched Phosphatidylcholine Exerted Superior Effects to Triglyceride in Ameliorating Obesity-Induced Osteoporosis Through Up-Regulating the Wnt/β-Catenin Pathway.

Metabolomics and physiological analysis of the effect of calcium supplements on reducing bone loss in ovariectomized rats by increasing estradiol levels

Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss

Differential effects of EPA and DHA on aging-related sarcopenia in mice and possible mechanisms involved

Emodin Promotes the Osteogenesis of MC3T3-E1 Cells Via BMP-9/Smad Pathway and Exerts a Preventive Effect in Ovariectomized Rats

Effect of Eicosapentaenoic Acid Supplementation on Murine Preadipocytes 3T3-L1 Cells Activated with Lipopolysaccharide and/or Tumor Necrosis Factor-α

Periplaneta Americana extract inhibits osteoclastic differentiation in vitro

Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model

Different N-6/N-3 PUFA Diets with Fish Oil Attenuated Osteoarthritis in Ovariectomized Mice Via Targeting the NLRP3 Inflammasome

Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota

Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin/calcineurin/Nfatc1 pathway

Bone targeting antioxidative nano-iron oxide for treating postmenopausal osteoporosis